CN101129691A - 当归疝气汤 - Google Patents
当归疝气汤 Download PDFInfo
- Publication number
- CN101129691A CN101129691A CNA2007101310151A CN200710131015A CN101129691A CN 101129691 A CN101129691 A CN 101129691A CN A2007101310151 A CNA2007101310151 A CN A2007101310151A CN 200710131015 A CN200710131015 A CN 200710131015A CN 101129691 A CN101129691 A CN 101129691A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- hernia
- amount
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010019909 Hernia Diseases 0.000 title claims abstract description 18
- 244000061520 Angelica archangelica Species 0.000 title 1
- 235000001287 Guettarda speciosa Nutrition 0.000 title 1
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 11
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 10
- 235000008504 concentrate Nutrition 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 7
- 238000005325 percolation Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000006188 syrup Substances 0.000 claims description 7
- 235000020357 syrup Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 235000010233 benzoic acid Nutrition 0.000 claims description 5
- 235000013736 caramel Nutrition 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 235000014347 soups Nutrition 0.000 claims description 5
- 241000218176 Corydalis Species 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 235000005911 diet Nutrition 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010037660 Pyrexia Diseases 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 206010029410 night sweats Diseases 0.000 abstract description 5
- 230000036565 night sweats Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241001533085 Aquilaria sinensis Species 0.000 abstract 1
- 241000282461 Canis lupus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 abstract 1
- 241000234653 Cyperus Species 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000002176 Foeniculum vulgare var vulgare Nutrition 0.000 abstract 1
- 241000546273 Lindera <angiosperm> Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 206010043354 Testicular swelling Diseases 0.000 abstract 1
- 235000007882 dietary composition Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 239000003814 drug Substances 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- -1 filter Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种清热利湿、活血益气、补肾益肝的药膳组合及其制备方法，主要由当归、茯苓、枸杞、肉桂、乌药、小茴香、海沉香、香附、白芍等配方配比，有良好的理气止痛、补益肝肾作用，尤其是对治疗男性疝气所引发的睾丸肿痛、潮热盗汗、腰脊酸痛等症状效果显著；除此之外，本发明还可作为保健的常用药膳，无副作用，服用方便，口感好，有较好的社会和经济效益。
Description
技术领域
本发明涉及一种治疗男性疝气所引发的睾丸肿痛、潮热盗汗、腰脊酸痛等症状的药膳组合及制备方法，尤其是清热利湿、活血益气、补肾益肝的汤剂。
背景技术
疝气又名小肠气，是腹内脏器由正常位置经腹壁上孔道或薄弱点突出而形成的包块，一般是咳嗽、便秘、生气、重体力劳动、排尿困难等因素引起腹腔压力突然增高冲破疝环腹膜所致，小儿常因啼哭引起，疝气可分为两大类，即水疝和小肠疝。
目前治疗疝气可分中医保守治疗和西医手术疗法，西医手术治疗较快，但需要至少3个月不参加重体力劳动或者剧烈运动，且复发率在15％左右，尤其是小儿疝气需要全麻，麻醉可能会对小儿大脑及生长发育有一定影响；中医保守治疗一般采用药物疗法，但很多药物在患者使用过程中都会带来一定的毒副作用，一般的生物制剂又在治疗效果上不能满足需要，更好地为患者减轻痛苦，少数药效比较好的配方及成剂，但成药的服用方式药效吸收差，不能有效治疗上述疾患。
发明内容
本发明的目的是提供一种服用方便、无副作用，治疗效果显著的药膳。
一种用于治疗男性疝气所引发的睾丸肿痛、潮热盗汗、腰脊酸痛等症状的药膳，所提供的技术方案是：取当归、茯苓、枸杞各15克，肉桂、乌药、小茴香各10克，海沉香4克，香附、白芍各6克，白糖适量，先将当归、茯苓、枸杞粉碎为粗末，用7倍量70％乙醇渗漉提取，滤过，浓缩并回收乙醇，将剩余药材用水煮提2次，滤过、浓缩，将白糖浓缩成糖浆，加入适量焦糖搅匀，将(上述渗漉)浓缩液与(煮提)液混合，加入苯甲酸(防腐剂)，搅匀过滤，并以蒸馏水调整至生产规定量，取上清液装入10ml已消毒、干燥的指型管所得的当归疝气汤。
为实现本发明所提供的制备方法包括以下步骤：
1、粉碎：将当归、茯苓、枸杞粉碎为不同规格的粗末；
2、渗漉：取上述粉碎粗末用7倍量70％乙醇渗漉提取，滤过，浓缩并回收乙醇；
3、煮提：取剩余药材用水煮提2次，第一次加水10倍量，煮沸2-3小时，第二次加水3倍量，煮沸2小时，两次滤液合并，滤过，然后浓缩；
4、炼糖：取白糖置锅内，加入50-60％的清水加热至沸，滤过，静置，取上清液浓缩成糖浆，加入适量焦糖搅匀；
5、混合：将(上述渗漉)浓缩液与(煮提)液混合，加入苯甲酸(防腐剂)，搅匀过滤，加入糖浆，搅拌均匀，并以蒸馏水调整至生产规定量；
6、罐装：取上清液装入10ml已消毒、干燥的指型管内；
当归味甘、辛，性温，主要药理作用如下：
★甘温质润，为补血要药，用于心肝血虚，面色萎黄，眩晕心悸等。
★既能补血、活血，又能调经，为妇科要药，用于血虚或血虚而兼有瘀滞的月经不调，痛经，经闭等症。
★补血活血，又兼能散寒止痛，用于血虚，血滞而兼有寒凝，以及跌打损伤，风湿痹阻的疼痛证。
★既能活血消肿止痛，又能补血生肌，为外科痈疽疮疡常用。
★养血润肠通便，用于血虚肠燥便秘。
枸杞子有滋补肝肾，明目，益面色，长肌肉，坚筋骨的功效，久服有延年益寿，延缓衰老的效果，治肝肾阴亏，腰膝酸软，头晕，目眩，目昏多泪，虚劳咳嗽，消渴，遗精等；枸杞子所含之营养成分非常丰富，每百克枸杞果中含粗蛋白4.49克，粗脂肪2.33克，碳水化合物9.12克，类胡萝卜素96毫克，硫胺素0.053毫克，核黄素0.137毫克，抗坏血酸19.8毫克，甜菜碱0.26毫克，还含有丰富的钾、钠、钙、镁、铁、铜、锰、锌等元素，以及22种氨基酸和多种维生素，枸杞多糖功能因子具有十分重要的多方面的保健功能作用：
(1)免疫调节作用
枸杞多糖对非特异性免疫、特异性免疫有非常显著的免疫调节作用，能显著地增强其脾淋巴细胞增殖、迟发型变态反应、升高血清溶血素含量，以及显著增强抗体生成的能力等。
(2)降血糖作用
枸杞多糖有明显的降血糖作用，有效率达100％，对正常血糖无影响。
(3)降血脂作用
枸杞多糖对血脂有明显影响，可显著降低血清固醇、甘油三脂含量、而对高密度脂蛋白有升高作用。
(4)延缓衰老作用
枸杞多糖可明显延长平均寿命及最高寿命，并有显著升高细胞的作用，另外能明显增强细胞的免疫功能。
(5)抗疲劳作用
构把多糖能加速血尿素的清除和降低运动后的血乳酸水平，能增强机体体力、迅速消除运动后的疲劳。
(6)其它作用
枸杞可显著延长人体缺氧条件下及辐射条件下的存活时间。
乌药性温、味辛，有理气止痛、温肾散寒的功效，可促进肠胃蠕动，用于胸腹胀痛、气逆喘急、膀胱虚冷、遗尿尿频、疝气、痛经等症。
本发明与现有技术相比，它不用吃药、打针，也不用住院治疗，服用方便，且制药成本低，比西医常用的药物疗法使患者满意率提高了30％，治愈率达到20％，有效率在90％以上，未发现有任何毒副作用，尤其是对治疗男性疝气所引发的睾丸肿痛、潮热盗汗、腰脊酸痛等症状效果显著；除此之外，本发明还可作为保健的常用药膳，具有清热利湿、活血益气、补肾益肝的功效，适合四季服用，无副作用，有较好的经济和社会效益。
具体实施方案
实际制药中，可将当归、茯苓、枸杞各15克，肉桂、乌药、小茴香各10克，海沉香4克，香附、白芍各6克，白糖适量，先将当归、茯苓、枸杞粉碎为粗末，用7倍量70％乙醇渗漉提取，滤过，浓缩并回收乙醇，将剩余药材用水煮提2次，滤过、浓缩，将白糖浓缩成糖浆，加入适量焦糖搅匀，将(上述渗漉)浓缩液与(煮提)液混合，加入苯甲酸(防腐剂)，搅匀过滤，并以蒸馏水调整至生产规定量，取上清液装入10ml已消毒、干燥的指型管所得的当归疝气汤，若有小腹胀痛，可加入木香、元胡各5克入药。
下面结合实施例对本发明的内容作进一步说明：
实施例一
配伍为：当归、茯苓、枸杞各15克，肉桂、乌药、小茴香各10克，海沉香4克，香附、白芍各6克，白糖适量。
制备方法：
1、粉碎：将当归、茯苓、枸杞粉碎为不同规格的粗末；
2、渗漉：取上述粉碎粗末用7倍量70％乙醇渗漉提取，滤过，浓缩并回收乙醇；
3、煮提：取剩余药材用水煮提2次，第一次加水10倍量，煮沸2-3小时，第二次加水3倍量，煮沸2小时，两次滤液合并，滤过，然后浓缩；
4、炼糖：取白糖置锅内，加入50-60％的清水加热至沸，滤过，静置，取上清液浓缩成糖浆，加入适量焦糖搅匀；
5、混合：将(上述渗漉)浓缩液与(煮提)液混合，加入苯甲酸(防腐剂)，搅匀过滤，加入糖浆，搅拌均匀，并以蒸馏水调整至生产规定量；
6、罐装：取上清液装入10ml已消毒、干燥的指型管内；
实施例二
配伍为：当归、茯苓、枸杞各15克，肉桂、乌药、小茴香各10克，海沉香4克，香附、白芍各6克，白糖适量，木香、元胡各5克，其制备方法同实施例一。
综上所述，本发明为黄色液体，气味芳香，味甘淡，其服用量可分为治疗和保健两种，对于患者来说可每日分2次服用，每次用量10ml，作为常人保健药膳服用时间不限，本发明无任何副作用，用药安全性能高，可每日1次服用；药物有效期为1-2年，配伍中的各药物及其制备方法是根据“中华人民共和国药典”选用。
本发明治疗的理论根据是以清热利湿、活血益气、补肾益肝的当归、茯苓、枸杞、肉桂、乌药、小茴香、海沉香、香附、白芍等作为原料，通过直接口服的方式给药，经临床试验表明，本发明有良好的理气止痛、补益肝肾的作用，有效率在90％以上，为临床治疗男性疝气所引发的睾丸肿痛、潮热盗汗、腰脊酸痛等症状提供了有力的依据。
Claims (2)
1.一种当归疝气汤，其特征在于当归、茯苓、枸杞各15克，肉桂、乌药、小茴香各10克，海沉香4克，香附、白芍各6克，白糖适量，先将当归、茯苓、枸杞粉碎为粗末，用7倍量70％乙醇渗漉提取，滤过，浓缩并回收乙醇，将剩余药材用水煮提2次，滤过、浓缩，将白糖浓缩成糖浆，加入适量焦糖搅匀，将(上述渗漉)浓缩液与(煮提)液混合，加入苯甲酸(防腐剂)，搅匀过滤，并以蒸馏水调整至生产规定量，取上清液装入10ml已消毒、干燥的指型管所得的当归疝气汤。
2.根据权利要求1所述，其特征在于配方配比组成为当归、茯苓、枸杞各15克，肉桂、乌药、小茴香各10克，海沉香4克，香附、白芍各6克，白糖适量，木香、元胡各5克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101310151A CN101129691A (zh) | 2007-08-20 | 2007-08-20 | 当归疝气汤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101310151A CN101129691A (zh) | 2007-08-20 | 2007-08-20 | 当归疝气汤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101129691A true CN101129691A (zh) | 2008-02-27 |
Family
ID=39127203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101310151A Pending CN101129691A (zh) | 2007-08-20 | 2007-08-20 | 当归疝气汤 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101129691A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824618A (zh) * | 2012-07-20 | 2012-12-19 | 李承平 | 一组行气止痛药片 |
| CN106377703A (zh) * | 2016-11-07 | 2017-02-08 | 陈中元 | 一种治疗睾丸肿痛的药物 |
-
2007
- 2007-08-20 CN CNA2007101310151A patent/CN101129691A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824618A (zh) * | 2012-07-20 | 2012-12-19 | 李承平 | 一组行气止痛药片 |
| CN106377703A (zh) * | 2016-11-07 | 2017-02-08 | 陈中元 | 一种治疗睾丸肿痛的药物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178911B (zh) | 用于阳虚、痰湿体质人祛风除湿、通络止痛的中药制剂及其制备方法和应用 | |
| CN104431178A (zh) | 一种降脂减肥保健茶 | |
| CN110038098A (zh) | 一种菊蒲清风茶及其制备方法 | |
| CN105861224A (zh) | 石斛养生酒及其制备方法 | |
| CN102178919B (zh) | 一种解酒口服中药 | |
| CN109528966A (zh) | 一种保健酒及其制作方法 | |
| CN101129614A (zh) | 健脾益气饮料 | |
| CN101129691A (zh) | 当归疝气汤 | |
| CN101129512A (zh) | 泽归口服液 | |
| CN114224963A (zh) | 一种用于增强免疫力缓解体力疲劳的中药制剂及其制备方法 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN1294854C (zh) | 一种纯天然中草药饮料 | |
| CN101199340A (zh) | 一种减肥保健食品及其制备方法 | |
| CN104740415A (zh) | 一种治疗哺乳期女性骨质疏松症的中药制剂 | |
| CN104815275A (zh) | 一种治疗妊娠反应的内服药物及其制备方法 | |
| CN109078157A (zh) | 一种抗肿瘤药物及其制备方法 | |
| CN108671116A (zh) | 用于治疗糖尿病的中草药组合物及其制备和服用方法 | |
| CN110812468B (zh) | 一种手掌参-37味蒙药膏方及其制备方法 | |
| CN102631496B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
| CN101129998A (zh) | 柴黄清胆饮料 | |
| CN101085323A (zh) | 治疗尿毒症的中药组合 | |
| CN106075278A (zh) | 一种多功能中药组合物 | |
| CN105950345A (zh) | 石斛酒及其制备方法 | |
| CN1268387C (zh) | 解酒口服液及其制作方法 | |
| CN102166295B (zh) | 一种治疗癌病的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080227 |